Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Adding 2 mL of BAC water to a 5 mg vial (2,500 mcg/mL) is a popular choice for easy measurement
TOP SELLING PRODUCTS Researched Benefits: BPC-157 TB-500 Blend 10MG is a research peptide combination consisting of two synthetic peptides, including BPC-157 (Body Protection Compound-157), which is derived from a protein found in human gastric juice and comprises 15 amino acids
Insurance coverage and out-of-pocket expenses can vary a lot
